Clinical Trials Browser

Phase 2/3 × Prostatic Neoplasms × enzalutamide × Clear all

NCT04787744 2026-04-08

VA STARPORT

Phase 2/3 Recruiting

Neoplasm Metastasis, Prostatic Neoplasms

NCT05627752 2024-02-28

Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage

Phase 2/3 Unknown

Prostatic Neoplasms

NCT00268476 2023-04-18

STAMPEDE

Phase 2/3 Active not recruiting

11,992 enrolled

Prostatic Neoplasms